Compounds and pharmaceutical compositions for the treatment...

Details Compounds and pharmaceutical compositions for the treatment... Compounds and pharmaceutical compositions for the treatment...

2011-05-31

2011-05-31

Shiao, Rei-tsang (Department: 1628)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S043000, C544S243000, C544S256000, C544S317000

Reexamination Certificate

active

07951789

ABSTRACT:
Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.

REFERENCES:
patent: 3480613 (1969-11-01), Walton
patent: 5627185 (1997-05-01), Gosselin et al.
patent: 6555676 (2003-04-01), Gosselin et al.
patent: 6653296 (2003-11-01), Holy et al.
patent: 6660721 (2003-12-01), Devos et al.
patent: 6752981 (2004-06-01), Erion et al.
patent: 6777395 (2004-08-01), Bhat et al.
patent: 6784166 (2004-08-01), Devos et al.
patent: 6787526 (2004-09-01), Bryant et al.
patent: 6812219 (2004-11-01), LaColla et al.
patent: 6846810 (2005-01-01), Martin et al.
patent: 6849726 (2005-02-01), Usman et al.
patent: 6852535 (2005-02-01), Thompson
patent: 6914054 (2005-07-01), Sommadossi et al.
patent: 6927291 (2005-08-01), Jin et al.
patent: 6984634 (2006-01-01), Cundy et al.
patent: 7022828 (2006-04-01), McSwiggen
patent: 7034009 (2006-04-01), Pavco et al.
patent: 7041817 (2006-05-01), Usman et al.
patent: 7094770 (2006-08-01), Watanabe et al.
patent: 7101861 (2006-09-01), Sommadossi et al.
patent: 7105493 (2006-09-01), Sommadossi et al.
patent: 7105499 (2006-09-01), Carroll et al.
patent: 7109165 (2006-09-01), Matulic-Adamic et al.
patent: 7125855 (2006-10-01), Bhat et al.
patent: 7144877 (2006-12-01), Gallop et al.
patent: 7157441 (2007-01-01), Sommadossi et al.
patent: 7176304 (2007-02-01), McSwiggen et al.
patent: 7202224 (2007-04-01), Eldrup et al.
patent: 2003/0060400 (2003-03-01), LaColla
patent: 2003/0219727 (2003-11-01), Becker et al.
patent: 2004/0023901 (2004-02-01), Cook
patent: 2004/0063658 (2004-04-01), Roberts et al.
patent: 2004/0121980 (2004-06-01), Martin et al.
patent: 2004/0209831 (2004-10-01), McSwiggen et al.
patent: 2004/0229839 (2004-11-01), Babu et al.
patent: 2004/0229840 (2004-11-01), Bhat et al.
patent: 2005/0009737 (2005-01-01), Clark
patent: 2005/0038240 (2005-02-01), Connolly et al.
patent: 2005/0182252 (2005-08-01), Reddy et al.
patent: 2005/0191302 (2005-09-01), Arthur et al.
patent: 2005/0203243 (2005-09-01), Polus
patent: 2005/0215510 (2005-09-01), Roberts et al.
patent: 2006/0040890 (2006-02-01), Martin et al.
patent: 2006/0046980 (2006-03-01), Erion et al.
patent: 2006/0111324 (2006-05-01), Choi et al.
patent: 2006/0234962 (2006-10-01), Olsen et al.
patent: 2006/0286615 (2006-12-01), Lederkremer et al.
patent: 2007/0037221 (2007-02-01), Block et al.
patent: 2007/0037735 (2007-02-01), Gosselin et al.
patent: 2007/0042939 (2007-02-01), LaColla
patent: 2007/0042940 (2007-02-01), LaColla et al.
patent: 2007/0042990 (2007-02-01), Gosselin et al.
patent: 2007/0042991 (2007-02-01), LaColla et al.
patent: 2007/0060498 (2007-03-01), Gosselin et al.
patent: 2007/0060503 (2007-03-01), Gosselin et al.
patent: 2007/0060504 (2007-03-01), Gosselin et al.
patent: 2007/0060505 (2007-03-01), Gosselin et al.
patent: 2007/0060541 (2007-03-01), Gosselin et al.
patent: 2007/0087960 (2007-04-01), Storer et al.
patent: 2008/0261913 (2008-10-01), Sommadossi et al.
patent: 101333235 (2008-12-01), None
patent: 1655033 (2006-10-01), None
patent: WO 88/00201 (1988-01-01), None
patent: WO 98/53813 (1998-12-01), None
patent: WO 01/32153 (2001-05-01), None
patent: WO 01/60315 (2001-08-01), None
patent: WO 01/79246 (2001-10-01), None
patent: WO 01/90121 (2001-11-01), None
patent: WO 01/92282 (2001-12-01), None
patent: WO 02/18404 (2002-03-01), None
patent: WO 02/32920 (2002-04-01), None
patent: WO 02/48165 (2002-06-01), None
patent: WO 02/057287 (2002-07-01), None
patent: WO 02/057425 (2002-07-01), None
patent: WO 03/062256 (2003-07-01), None
patent: WO 03/070750 (2003-08-01), None
patent: WO 03/105770 (2003-12-01), None
patent: WO 2004/002422 (2004-01-01), None
patent: WO 2004/002999 (2004-01-01), None
patent: WO 2004/003000 (2004-01-01), None
patent: WO 2004/003138 (2004-01-01), None
patent: WO 2004/009020 (2004-01-01), None
patent: WO 2004/022999 (2004-03-01), None
patent: WO 2004/072090 (2004-08-01), None
patent: WO 2004/096233 (2004-11-01), None
patent: WO 2004/096234 (2004-11-01), None
patent: WO 2004/096237 (2004-11-01), None
patent: WO 2004/096285 (2004-11-01), None
patent: WO 2004/096286 (2004-11-01), None
patent: WO 2004/096287 (2004-11-01), None
patent: WO 2004/100960 (2004-11-01), None
patent: WO 2004/000858 (2004-12-01), None
patent: WO 2005/012525 (2005-02-01), None
patent: WO 2005/021568 (2005-03-01), None
patent: WO 2005/021568 (2005-03-01), None
patent: WO 2005/044279 (2005-05-01), None
patent: WO 2005/044308 (2005-05-01), None
patent: WO 2005/087788 (2005-09-01), None
patent: WO 2006/012078 (2006-02-01), None
patent: WO 2006/012440 (2006-02-01), None
patent: WO 2006/116557 (2006-02-01), None
patent: WO 2006/063149 (2006-06-01), None
patent: WO 2006/093987 (2006-09-01), None
patent: WO 2006/094347 (2006-09-01), None
patent: WO 2006/116512 (2006-11-01), None
patent: WO 2007/020193 (2007-02-01), None
patent: WO 2007/095269 (2007-08-01), None
patent: WO 2008/062206 (2008-05-01), None
patent: WO 2008/082602 (2008-07-01), None
Egron et al., 2001, CAS: 136:20199.
Ballatore, et al., “Synthesis and Evaluation of Novel Amidate Prodrugs of PMEA and PMPA,” Bioorganic & Medicinal Chemistry Letters 11, 2001 1053-1056.
Beltran, et al., “Rational Design of a New Series of Pronucleotide,” Bioorganic & Medicinal Chemistry Letters, 11, 2001, 1775-1777.
Birkus, Cathepsin A Is the Major Hydrolase Catalyzing the Intracellular Hydrolysis of the Antiretroviral Nucleotide Phosphonoamidate Prodrugs GS-7340 and GS-9131, Antimicrobial Agents and Chemotherapy, 2007, 543-550.
Cahard, et al., “Aryloxy Phosphoramidate Triesters as Pro-Tides,” Mini-Reviews in Medicinal Chemistry, 2004, 4, 371-382.
Chapman, et al., “Practical Synthesis, Separation, and Stereochemical Assignment of the PMPA Pro-Drub GS-7340,” Nucleosides, Nucleotides & Nucleic Acids, 20(4-7), 621-628, 2001.
Chapman, et al., Purification of PMPA Amidate Prodrugs by SMB Chromatography and X-Ray Crystallography of the Diastereomerically Pure GS-7340, Nucleosides, Nucleotides & Nucleic Acids, 20(4-7), 1085-1090 , 2001.
Chou et al., “Phosphoramidate Pronucleotides: A Comparison of the Phosphoramidase Substrate Specificity of Human andEscherichia coliHistidine Triad Nucleotide Binding Proteins,” Molecular Pharmaceutics, vol. 4, No. 2, 208-217, 2006.
Drontle, et al., Designing a Pronucleotide Stratagem: Lessons from Amino Acid Phosphoramidates of Anticancer and Antiviral Pyrimidines, Mini-Reviews in Medicinal Chemistry, vol. 4, No. 4, 409-419, 2004.
Egron, et al., “S-Acyl-2-thioethyl Phosphoramidate Diester Derivatives as Mononucleotide Prodrugs,” J. Med. Chem., 46, 4564-4571, 2003.
Ergon , D.; Gosselin, G.; Bryant M.; Sommadossi J.-P.; Imbach J.-L., “Synthesis and study of antiviral S-acyl-2-thioethyl (SATE) phosphoramidate derivatives of b-L-ddA”, Antiviral Research, 2001, 50 (1), A45.
Egron, et al., “Synthesis and Anti-HIV Activity of Some S-Acyl-2-Thioethyl (SATE) Phosphoramidate Derivatives of 3′-Azido-2″,3″-Dideoxythymidine,” Nucleosides and Nucleotides, 18(4&5), 981-982, 1999.
Egron, “Synthesis and study of antiviral S-acyl-2-thioethyl (SATE) phosphoramidate derivatives of B-L-ddA.” Submitted for 14thInternational Conference on Antiviral Research, Seattle, WA; Apr. 8-13, 2001.
Egron, et al., “Synthesis and Study of a New Series of Phosphoramidate Derivatives as Mononucleotide Prodrugs,” Nucleosides, Nucleotides, 20(4-7), 751-754, 2001.
Eisenberg, et al., “Metabolism of GS-7340, A Novel Phenyl Monophosphoramidate Intracellular Prodrub of PMPA, in Blood,” Nucleosides, Nucleotides 20 (4-7), 1091-1098, 2001.
Erion, et al., “Targeting thyroid hormone receptor-B agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index,” PNAS, vol. 104, No. 39, 15490-15495, 2007.
Hecker, e

Affiliated with

Also associated with

Rating

Compounds and pharmaceutical compositions for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and pharmaceutical compositions for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and pharmaceutical compositions for the treatment... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2666198